NASDAQ:AURA
Aura Biosciences, Inc.
- Stock
Last Close
5.41
06/11 21:00
Market Cap
367.12M
Beta: -
Volume Today
157.64K
Avg: 116.01K
PE Ratio
−3.16
PFCF: −5.86
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 1.47M - | 1.51M 2.34% | 2.66M 76.69% | 2.35M 11.54% | ||
average receivables | ||||||
book value per share | -6.29 - | -5.56 11.68% | 29.52 631.26% | 6.53 77.87% | 0.01 99.91% | |
capex per share | -0.16 - | -0.04 75.35% | -0.41 945.08% | -0.04 91.13% | -0.00 99.95% | |
capex to depreciation | -4.36 - | -0.93 78.74% | -2.56 175.62% | -0.93 63.65% | -0.55 41.10% | |
capex to operating cash flow | 0.11 - | 0.03 70.50% | 0.07 106.83% | 0.02 69.44% | 0.01 44.58% | |
capex to revenue | ||||||
cash per share | 2.34 - | 0.89 61.94% | 28.89 3,149.68% | 6.31 78.17% | 0.01 99.91% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 0.00 - | 0.00 48.68% | 0.01 797.81% | 0.09 1,428.79% | 0.08 17.68% | |
debt to equity | -0.00 - | -0.00 75.39% | 0.01 4,739.30% | 0.11 1,566.02% | 0.09 18.80% | |
dividend yield | ||||||
earnings yield | -0.12 - | -0.08 34.85% | -0.39 412.23% | -0.18 53.66% | -0.00 99.88% | |
enterprise value | 173.22M - | 272.19M 57.13% | -60.47M 122.22% | 213.62M 453.25% | 351.01B 164,218.47% | |
enterprise value over ebitda | -7.33 - | -12.73 73.72% | 1.72 113.48% | -3.56 307.56% | -4.59K 128,632.77% | |
ev to operating cash flow | -8.38 - | -11.19 33.52% | 1.87 116.67% | -3.91 309.68% | -5.50K 140,422.70% | |
ev to sales | ||||||
free cash flow per share | -1.65 - | -1.28 22.15% | -6.69 421.88% | -1.86 72.20% | -0.00 99.91% | |
free cash flow yield | -0.11 - | -0.09 22.15% | -0.39 354.88% | -0.18 55.05% | -0.00 99.90% | |
graham net net | -6.62 - | -5.80 12.46% | 27.39 572.53% | 5.36 80.43% | 0.00 99.91% | |
graham number | 15.70 - | 11.91 24.14% | 66.56 458.76% | 16.76 74.82% | 0.02 99.91% | |
income quality | 0.85 - | 1.10 28.25% | 0.92 16.05% | 0.93 1.06% | 0.84 10.07% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -4.83K - | -7.40K 53.31% | -2.71K 63.37% | 70.94 102.62% | ||
interest debt per share | 0.00 - | 0.00 76.33% | 0.19 20,712.73% | 0.67 249.05% | 0.00 99.93% | |
inventory turnover | ||||||
invested capital | -0.00 - | -0.00 75.39% | 0.01 4,739.30% | 0.11 1,566.02% | 0.09 18.80% | |
market cap | 205.62M - | 289.57M 40.82% | 87.62M 69.74% | 314.34M 258.77% | 351.03B 111,572.88% | |
net current asset value | -91.11M - | -112.36M 23.32% | 145.99M 229.93% | 168.35M 15.32% | 202.57M 20.32% | |
net debt to ebitda | 1.37 - | 0.81 40.70% | 4.20 416.94% | 1.68 60.03% | 0.28 83.27% | |
net income per share | -1.74 - | -1.14 34.85% | -6.67 487.68% | -1.91 71.34% | -0.00 99.90% | |
operating cash flow per share | -1.49 - | -1.24 16.43% | -6.28 405.29% | -1.82 70.96% | -0.00 99.91% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.65 - | -1.00 53.82% | -0.22 78.59% | -0.26 18.82% | -0.30 17.21% | |
revenue per share | ||||||
roe | 0.28 - | 0.20 26.23% | -0.23 210.62% | -0.29 29.48% | -0.34 15.62% | |
roic | 0.28 - | 0.20 26.08% | -0.22 209.20% | -0.25 10.91% | -0.29 16.53% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -6.29 - | -5.56 11.68% | 29.52 631.26% | 6.53 77.87% | 0.01 99.91% | |
stock based compensation to revenue | ||||||
tangible asset value | -87.41M - | -108.71M 24.38% | 152.31M 240.11% | 195.58M 28.41% | 225.85M 15.47% | |
tangible book value per share | -6.29 - | -5.56 11.68% | 29.52 631.26% | 6.53 77.87% | 0.01 99.91% | |
working capital | 27.20M - | 15.79M 41.93% | 146.43M 827.14% | 186.25M 27.19% | 219.44M 17.82% |
All numbers in USD (except ratios and percentages)